WeVote

Bill

Bill

HB 1089

Controlled substances; ivermectin as an over-the-counter medication; provide

2025-2026 Regular Session Introduced by Charlice Byrd and 4 co-sponsors

Georgia bill reclassifies ivermectin as over-the-counter medication, eliminating prescription requirements and physician oversight for the controversial antiparasitic drug.

House Committee Favorably Reported By Substitute
0
WeVote Research Nonpartisan
Bill Summary · HB 1089

Legislative bill overview

HB 1089 would reclassify ivermectin as an over-the-counter medication in Georgia, removing it from controlled substance regulations. This would allow individuals to purchase ivermectin without a prescription, similar to common cold or allergy medications.

Why is this important

Ivermectin's regulatory status has become highly contentious following debates about its use for COVID-19 treatment. The bill reflects ongoing disagreement about medication access, medical autonomy, and the role of prescriber oversight in pharmaceutical safety. This could significantly shift how Georgians access a drug with both FDA-approved uses (parasitic infections) and significant off-label usage controversy.

Potential points of contention

  • Medical safety and prescriber oversight: Removing prescription requirements eliminates physician evaluation of patient suitability, dosing appropriateness, and drug interactions—particularly concerning given ivermectin's potential toxicity at high doses
  • FDA approval scope: Ivermectin is FDA-approved only for specific parasitic infections; OTC status could encourage unapproved uses that lack clinical evidence
  • Public health messaging: OTC availability during ongoing debate about ivermectin's COVID-19 efficacy (which major health organizations do not support) could undermine public health communication and increase misuse

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.